InVivoMAb anti-WNV E protein DIII-LR

Bennett AK, Richner M, Mun MD, et al. Type I IFN stimulates lymph node stromal cells from adult and old mice during a West Nile virus infection. Aging Cell. 2023,22(4):e13796. doi: 10.1111/acel.13796

He J, Lai H, Esqueda A, et al. Plant-Produced Antigen Displaying Virus-Like Particles Evokes Potent Antibody Responses against West Nile Virus in Mice. Vaccines (Basel). 2021,9(1). doi: 10.3390/vaccines9010060

Goo L, Debbink K, Kose N, et al. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions. Nat Microbiol. 2019,4(1):71-77. doi: 10.1038/s41564-018-0283-7

Kim S, Pinto AK, Myers NB, et al. A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. Eur J Immunol. 2014,44(7):1936-46. doi: 10.1002/eji.201444450

Lin TY, Dowd KA, Manhart CJ, et al. A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus. J Virol. 2012,86(7):3501-12. doi: 10.1128/JVI.06435-11

Szretter KJ, Brien JD, Thackray LB, et al. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol. 2011,85(22):11557-66. doi: 10.1128/JVI.05519-11

Dowd KA, Jost CA, Durbin AP, et al. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog. 2011,7(6):e1002111. doi: 10.1371/journal.ppat.1002111

Schneeweiss A, Chabierski S, Salomo M, et al. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Vaccine. 2011,29(37):6352-7. doi: 10.1016/j.vaccine.2011.04.116

Thompson BS, Moesker B, Smit JM, et al. A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog. 2009,5(5):e1000453. doi: 10.1371/journal.ppat.1000453

Daffis S, Samuel MA, Suthar MS, et al. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008,82(21):10349-58. doi: 10.1128/JVI.00935-08